CARIS LIFE SCIENCES
Live / Registered — Registered (as of 06 Oct 2026)
What this means for you
Registered since 06 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99000412
- Registration number
- 8488000
- Mark type
- Design + words
- Filed
- 16 Jan 2025
- Published for opposition
- 12 Aug 2025
- Registered
- 06 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 06 Oct 2032 (grace period to 06 Apr 2033)
- Attorney of record
- Anne Fleeson
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes
- Class 044 — Medical, beauty and agricultural services: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services
Owner
- Caris MPI, Inc., Irving, TX, US
- Caris MPI, Inc., Irving, TX, US
- Caris MPI, Inc., Irving, TX, US
Prosecution history
- 06 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2026 — USE AMENDMENT FILED
- 16 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 18 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2026 — SOU EXTENSION 1 GRANTED
- 17 Mar 2026 — SOU EXTENSION 1 FILED
- 17 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED